Author: Lin, Ling; Lu, Lianfeng; Cao, Wei; Li, Taisheng
Title: Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia Cord-id: 9iv1krak Document date: 2020_3_30
ID: 9iv1krak
Snippet: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact as the main means of transmission. Since the first case appeared in Wuhan, China, in December 2019, the outbreak has gradually spread nationwide. Up to now, according to official data released by the Chinese health commission, the number of newly diagnosed patients has been declining, and the epidemic is gradually being controlled. Although
Document: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact as the main means of transmission. Since the first case appeared in Wuhan, China, in December 2019, the outbreak has gradually spread nationwide. Up to now, according to official data released by the Chinese health commission, the number of newly diagnosed patients has been declining, and the epidemic is gradually being controlled. Although most patients have mild symptoms and good prognosis after infection, some patients developed severe and die from multiple organ complications. The pathogenesis of SARS-CoV-2 infection in humans remains unclear. Immune function is a strong defense against invasive pathogens and there is currently no specific antiviral drug against the virus. This article reviews the immunological changes of coronaviruses like SARS, MERS and other viral pneumonia similar to SARS-CoV-2. Combined with the published literature, the potential pathogenesis of COVID-19 is inferred, and the treatment recommendations for giving high-doses intravenous immunoglobulin and low-molecular-weight heparin anticoagulant therapy to severe type patients are proposed.
Search related documents:
Co phrase search for related documents- abnormal change and lymphocyte change: 1
- acid testing and acute patient: 1, 2, 3, 4, 5
- acid testing and acute phase: 1, 2, 3
- acid testing and acute respiratory distress: 1, 2
- acid testing and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acid testing and lung blood: 1
- acid testing and lung lesion: 1, 2
- acid testing and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acid testing and lymphocyte increase: 1, 2
- acid testing and lymphocyte subgroup: 1
- acute patient and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
- acute patient and lung blood: 1, 2, 3, 4
- acute patient and lymphocyte count: 1, 2, 3, 4, 5
- acute patient and lymphocyte increase: 1
- acute patient and lymphocyte response: 1, 2
Co phrase search for related documents, hyperlinks ordered by date